View in EDS HTML Full Text PDF Full Text

Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma.
Authors: Muramatsu, Ayako1,2 (AUTHOR), Kobayashi, Tsutomu1 (AUTHOR), Kawaji-Kanayama, Yuka1,2 (AUTHOR), Uchiyama, Hitoji2 (AUTHOR), Sasaki, Nana3 (AUTHOR), Uoshima, Nobuhiko3 (AUTHOR), Nakao, Mitsushige4 (AUTHOR), Takahashi, Ryoichi5 (AUTHOR), Shimura, Kazuho6 (AUTHOR), Kaneko, Hiroto6 (AUTHOR), Kiyota, Miki7 (AUTHOR), Wada, Katsuya7 (AUTHOR), Chinen, Yoshiaki1,8 (AUTHOR), Hirakawa, Koichi8 (AUTHOR), Fuchida, Shin-ichi9 (AUTHOR), Shimazaki, Chihiro9 (AUTHOR), Mizutani, Shinsuke1 (AUTHOR), Tsukamoto, Taku1 (AUTHOR), Shimura, Yuji1 (AUTHOR), Taniwaki, Masafumi6,10 (AUTHOR)
Source: Leukemia & Lymphoma. Jul2022, Vol. 63 Issue 7, p1678-1685. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2022.2038373